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Background
Cervical cancer (CC) is most common cancer among
women in Africa and in women living with HIV [1,2].
Its prevalence has remained stable or increasing with
introduction of HAART suggesting complex interactions
with HIV [3,4]. Current screening programs can sub-
stantially reduce all-cause mortality of CC but imple-
mentation in LMIC is hobbled by poor infrastructure,
cost and lack of personnel. Nurse provider led, minimal
visit, screen and treat programs offer an opportunity to
reduce CC morbidity and mortality in LMIC [5]. In this
study we evaluate the implementation of cervical cancer
screen and treat programs at 2 HIV treatment and pre-
vention sites in Nigeria.
Material and methods
CC screening programs using nurse providers, VIA, off
the shelf camera for digital cervicography, treatment of
eligible lesions by cold coagulation and referral as
required was implemented at 2 PEPFAR supported sites
in Abuja, Central Nigeria. QA was provided by Gynecol-
ogist and based on weekly review of digital cervico-
graphs and client recall as required.
Results
From July 2010 to July 2011, 2002 HIV+ women had
been screened for CC at the 2 sites, but only data on
925 is reported in this abstract. Mean (SD) age was 35.2
(7.0) years; mean (sd) age at sexual debut was 19.0 (3.9)
years; range, mean, sd of pregnancies was 0 – 16, 3.4,
2.5; range, mean, sd of pregnancies was 0 – 1 2 ,1 . 6 ,1 . 8 ;
range, mean, sd of most recent cd4 count before screen-
ing was 11 – 1197, 466.7, 239.0; 6.8% were VIA positive;
0.2% had invasive CC and 0.2% were uncertain. Concor-
dance between the clinical review and nursing diagnosis
was 65% at the beginning of the program but reached
100% after 3 months.
Conclusions
This study showed nurse provider led CC screening and
treatment program is a viable public health intervention
among PLWHIV in Nigeria.
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